Among these alternative splicing events, RBM4, Nova1, SRSF6, and vascular endothelial growth factor 165 (VEGF165) comprised a splicing cascade in a consensus sequence-dependent manner which manipulated the migration and angiogenetic signature of CRC cells. The gene discussed is NOVA1; the disease is colorectal carcinoma.